Cargando…

A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota

Antibiotics offer an efficient means for managing diseases caused by bacterial pathogens. However, antibiotics are typically broad spectrum and they can indiscriminately kill beneficial microbes in body habitats such as the gut, deleteriously affecting the commensal gut microbiota. In addition, many...

Descripción completa

Detalles Bibliográficos
Autores principales: Cieplak, Tomasz, Soffer, Nitzan, Sulakvelidze, Alexander, Nielsen, Dennis Sandris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219645/
https://www.ncbi.nlm.nih.gov/pubmed/29517960
http://dx.doi.org/10.1080/19490976.2018.1447291
_version_ 1783368691347357696
author Cieplak, Tomasz
Soffer, Nitzan
Sulakvelidze, Alexander
Nielsen, Dennis Sandris
author_facet Cieplak, Tomasz
Soffer, Nitzan
Sulakvelidze, Alexander
Nielsen, Dennis Sandris
author_sort Cieplak, Tomasz
collection PubMed
description Antibiotics offer an efficient means for managing diseases caused by bacterial pathogens. However, antibiotics are typically broad spectrum and they can indiscriminately kill beneficial microbes in body habitats such as the gut, deleteriously affecting the commensal gut microbiota. In addition, many bacteria have developed or are developing resistance to antibiotics, which complicates treatment and creates significant challenges in clinical medicine. Therefore, there is a real and urgent medical need to develop alternative antimicrobial approaches that will kill specific problem-causing bacteria without disturbing a normal, and often beneficial, gut microbiota. One such potential alternative approach is the use of lytic bacteriophages for managing bacterial infections, including those caused by multidrug-resistant pathogens. In the present study, we comparatively analysed the efficacy of a bacteriophage cocktail targeting Escherichia coli with that of a broad-spectrum antibiotic (ciprofloxacin) using an in vitro model of the small intestine. The parameters examined included (i) the impact on a specific, pre-chosen targeted E. coli strain, and (ii) the impact on a selected non-targeted bacterial population, which was chosen to represent a defined microbial consortium typical of a healthy small intestine. During these studies, we also examined stability of bacteriophages against various pH and bile concentrations commonly found in the intestinal tract of humans. The bacteriophage cocktail was slightly more stable in the simulated duodenum conditions compared to the simulated ileum (0.12 vs. 0.58 log decrease in phage titers, respectively). It was equally effective as ciprofloxacin in reducing E. coli in the simulated gut conditions (2–3 log reduction), but had much milder (none) impact on the commensal, non-targeted bacteria compared to the antibiotic.
format Online
Article
Text
id pubmed-6219645
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-62196452018-11-07 A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota Cieplak, Tomasz Soffer, Nitzan Sulakvelidze, Alexander Nielsen, Dennis Sandris Gut Microbes Brief Report Antibiotics offer an efficient means for managing diseases caused by bacterial pathogens. However, antibiotics are typically broad spectrum and they can indiscriminately kill beneficial microbes in body habitats such as the gut, deleteriously affecting the commensal gut microbiota. In addition, many bacteria have developed or are developing resistance to antibiotics, which complicates treatment and creates significant challenges in clinical medicine. Therefore, there is a real and urgent medical need to develop alternative antimicrobial approaches that will kill specific problem-causing bacteria without disturbing a normal, and often beneficial, gut microbiota. One such potential alternative approach is the use of lytic bacteriophages for managing bacterial infections, including those caused by multidrug-resistant pathogens. In the present study, we comparatively analysed the efficacy of a bacteriophage cocktail targeting Escherichia coli with that of a broad-spectrum antibiotic (ciprofloxacin) using an in vitro model of the small intestine. The parameters examined included (i) the impact on a specific, pre-chosen targeted E. coli strain, and (ii) the impact on a selected non-targeted bacterial population, which was chosen to represent a defined microbial consortium typical of a healthy small intestine. During these studies, we also examined stability of bacteriophages against various pH and bile concentrations commonly found in the intestinal tract of humans. The bacteriophage cocktail was slightly more stable in the simulated duodenum conditions compared to the simulated ileum (0.12 vs. 0.58 log decrease in phage titers, respectively). It was equally effective as ciprofloxacin in reducing E. coli in the simulated gut conditions (2–3 log reduction), but had much milder (none) impact on the commensal, non-targeted bacteria compared to the antibiotic. Taylor & Francis 2018-08-24 /pmc/articles/PMC6219645/ /pubmed/29517960 http://dx.doi.org/10.1080/19490976.2018.1447291 Text en © 2018 The Authors. Published with license by Taylor & Francis http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Brief Report
Cieplak, Tomasz
Soffer, Nitzan
Sulakvelidze, Alexander
Nielsen, Dennis Sandris
A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota
title A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota
title_full A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota
title_fullStr A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota
title_full_unstemmed A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota
title_short A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota
title_sort bacteriophage cocktail targeting escherichia coli reduces e. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219645/
https://www.ncbi.nlm.nih.gov/pubmed/29517960
http://dx.doi.org/10.1080/19490976.2018.1447291
work_keys_str_mv AT cieplaktomasz abacteriophagecocktailtargetingescherichiacolireducesecoliinsimulatedgutconditionswhilepreservinganontargetedrepresentativecommensalnormalmicrobiota
AT soffernitzan abacteriophagecocktailtargetingescherichiacolireducesecoliinsimulatedgutconditionswhilepreservinganontargetedrepresentativecommensalnormalmicrobiota
AT sulakvelidzealexander abacteriophagecocktailtargetingescherichiacolireducesecoliinsimulatedgutconditionswhilepreservinganontargetedrepresentativecommensalnormalmicrobiota
AT nielsendennissandris abacteriophagecocktailtargetingescherichiacolireducesecoliinsimulatedgutconditionswhilepreservinganontargetedrepresentativecommensalnormalmicrobiota
AT cieplaktomasz bacteriophagecocktailtargetingescherichiacolireducesecoliinsimulatedgutconditionswhilepreservinganontargetedrepresentativecommensalnormalmicrobiota
AT soffernitzan bacteriophagecocktailtargetingescherichiacolireducesecoliinsimulatedgutconditionswhilepreservinganontargetedrepresentativecommensalnormalmicrobiota
AT sulakvelidzealexander bacteriophagecocktailtargetingescherichiacolireducesecoliinsimulatedgutconditionswhilepreservinganontargetedrepresentativecommensalnormalmicrobiota
AT nielsendennissandris bacteriophagecocktailtargetingescherichiacolireducesecoliinsimulatedgutconditionswhilepreservinganontargetedrepresentativecommensalnormalmicrobiota